Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Payables (2016 - 2025)

Historic Payables for Innovate (VATE) over the last 16 years, with Q3 2025 value amounting to $99.9 million.

  • Innovate's Payables rose 1935.48% to $99.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.9 million, marking a year-over-year increase of 1935.48%. This contributed to the annual value of $84.8 million for FY2024, which is 4065.78% down from last year.
  • As of Q3 2025, Innovate's Payables stood at $99.9 million, which was up 1935.48% from $80.2 million recorded in Q2 2025.
  • In the past 5 years, Innovate's Payables registered a high of $213.0 million during Q3 2022, and its lowest value of $70.2 million during Q1 2021.
  • Moreover, its 5-year median value for Payables was $142.9 million (2023), whereas its average is $141.1 million.
  • Its Payables has fluctuated over the past 5 years, first tumbled by 7900.72% in 2021, then skyrocketed by 18547.01% in 2022.
  • Over the past 5 years, Innovate's Payables (Quarter) stood at $179.2 million in 2021, then grew by 13.0% to $202.5 million in 2022, then dropped by 29.43% to $142.9 million in 2023, then crashed by 40.66% to $84.8 million in 2024, then rose by 17.81% to $99.9 million in 2025.
  • Its Payables stands at $99.9 million for Q3 2025, versus $80.2 million for Q2 2025 and $104.7 million for Q1 2025.